Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions
Original Article
C. Zhou, K.-J. Tang, B.C. Cho, B. Liu, L. Paz-Ares, S. Cheng, S. Kitazono, M. Thiagarajan, J.W. Goldman, J.K. Sabari, R.E. Sanborn, A.S. Mansfield, J.-Y. Hung, M. Boyer, S. Popat, J.M. Dias, E. Felip, M. Majem, M. Gumus, S. Kim, A. Ono, J. Xie, A. Bhattacharya, T. Agrawal, S.M. Shreeve, R.E. Knoblauch, K. Park, and N. Girard
N Engl J Med 2023;389:2039-2051
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation